Comments
Loading...
Aligos Therapeutics (ALGS) Forecast
NewsEarningsAligos Therapeutics (ALGS) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestAligos Therapeutics (NASDAQ:ALGS) Stock Quotes, Forecast and News Summary
Aligos Therapeutics Stock (NASDAQ: ALGS) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Aligos Therapeutics (ALGS) stock?
You can purchase shares of Aligos Therapeutics (NASDAQ:ALGS) through any online brokerage.
Who are Aligos Therapeutics (ALGS) competitors?
Other companies in Aligos Therapeutics’s space includes: CytomX Therapeutics (NASDAQ:CTMX), bluebird bio (NASDAQ:BLUE), Cellectar Biosciences (NASDAQ:CLRB), Connect Biopharma Hldgs (NASDAQ:CNTB) and Immuneering (NASDAQ:IMRX).
What is the forecast, or price target, for Aligos Therapeutics (ALGS) stock?
Aligos Therapeutics has a consensus price target of $19.80.
What is the current price for Aligos Therapeutics (ALGS)?
The stock price for Aligos Therapeutics (NASDAQ: ALGS) is $18.04 last updated November 21, 2024 at 9:15 AM EST.
Does Aligos Therapeutics (ALGS) pay a dividend?
There are no upcoming dividends for Aligos Therapeutics.
When is Aligos Therapeutics (NASDAQ:ALGS) reporting earnings?
Aligos Therapeutics’s Q3 earnings are confirmed for Wednesday, November 6, 2024.
Is Aligos Therapeutics (ALGS) going to split?
There is no upcoming split for Aligos Therapeutics.
What sector and industry does Aligos Therapeutics (ALGS) operate in?
Aligos Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.